Nuevolution

Copenhagen, Denmark Founded: 2001 • Age: 25 yrs Acquired By Amgen
Drug treatments for oncology and chronic inflammatory diseases are developed.
Request Access

About Nuevolution

Nuevolution is a company based in Copenhagen (Denmark) founded in 2001 was acquired by Amgen in May 2019.. Nuevolution has raised $12.45 million across 2 funding rounds from investors including Amgen, SEB and Sunstone. Nuevolution operates in a competitive market with competitors including Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.

  • Headquarter Copenhagen, Denmark
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $12.45 M (USD)

    in 2 rounds

  • Latest Funding Round
    $12.45 M (USD), Series B

    Jun 19, 2012

  • Investors
    Amgen

    & 5 more

  • Employee Count
    Employee Count
  • Acquired by
    Amgen

    (May 26, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Nuevolution

Nuevolution has successfully raised a total of $12.45M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.45 million completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $12.5M
  • First Round
  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2012 Amount Series B - Nuevolution Valuation Industrifonden
Oct, 2003 Amount Series B - Nuevolution Valuation SLS Venture , Novo Holdings
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nuevolution

Nuevolution has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, SEB and Sunstone. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by Sunstone in early-stage European companies.
Founded Year Domain Location
Investments in deep-tech, life sciences, and transformative tech are managed.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nuevolution

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nuevolution

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nuevolution Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nuevolution

Nuevolution operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
Gene therapies for rare diseases are developed to treat patients.
domain founded_year HQ Location
Gene therapies for rare diseases including retinal dystrophies are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nuevolution

Frequently Asked Questions about Nuevolution

When was Nuevolution founded?

Nuevolution was founded in 2001 and raised its 1st funding round 2 years after it was founded.

Where is Nuevolution located?

Nuevolution is headquartered in Copenhagen, Denmark.

Is Nuevolution a funded company?

Nuevolution is a funded company, having raised a total of $12.45M across 2 funding rounds to date.

What does Nuevolution do?

Founded in 2001 and based in Copenhagen, Denmark, drug treatments targeting oncology and chronic inflammatory diseases are developed by the company. Operations focus on biotechnology, utilizing Chemics technology for synthesizing Chemetics molecules that combine drugs, DNA tags, and linkers. High-throughput screening identifies active compounds, followed by optimization from hit identification to lead stages. The domain nuevolution.com supports these activities in the pharmaceutical sector.

Who are the top competitors of Nuevolution?

Nuevolution's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.

Who are Nuevolution's investors?

Nuevolution has 6 investors. Key investors include Amgen, SEB, Sunstone, Industrifonden, and SLS Venture.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available